Key result
Pre-diabetes is linked to ~2.4-fold higher odds of significant CAD in NSTE-ACS.
Why the study?
Pre-diabetes is associated with increased cardiovascular risk, but its relationship with severity of coronary artery disease and ischemic mitral regurgitation in NSTE-ACS patients was unclear.
Does pre-diabetes increase the risk of significant coronary artery disease and ischemic mitral regurgitation in patients with non-ST-segment elevation acute coronary syndrome?
Case-Control (n=200)
Blinded assessors
No
Does pre-diabetes increase the risk of significant coronary artery disease and ischemic mitral regurgitation in patients with non-ST-segment elevation acute coronary syndrome?
In patients with non-ST-segment elevation acute coronary syndrome, pre-diabetes is an independent predictor of having significant coronary artery disease and severe ischemic mitral regurgitation.
Answers are grounded in this paper and cite their sources.
Pre-diabetes signals higher CAD odds in NSTE-ACS; hypothesis-generating for intervention trials, should not yet change practice.
Pre-diabetes is associated with an increased risk of developing cardiovascular disease (CVD). We aimed to investigate the association between pre-diabetes and the severity of coronary artery disease, along with other high-risk markers—such as ischemic mitral regurgitation (MR)—in non-diabetic patients hospitalized with NSTE-ACS. This study was a case control study on 200 non-diabetic patients including equal size of consecutive pre-diabetic and normoglycemic individuals with NSTE-ACS. All patients underwent an echocardiography to determine the left ventricular ejection fraction, prevalence and existence of ischemic mitral regurgitation (MR), and right ventricular size and function. After that, coronary angiography (CAG) was performed to assess the significance of coronary artery disease (CAD) and to calculate the SYNTAX score. pre-diabetic patients were older and had higher prevalence of hypertension than normoglycemic group ( P value<0.001 and 0.001, respectively). Also, significant CAD (86 % vs. 74 %, P value = 0.034) and severe ischemic MR (16 % vs. 6 %, P value = 0.024) were more prevalent in pre-diabetic patients than in normoglycemic patients, whereas the absence of MR was more common in normoglycemic patients (21 % vs. 3 %, P value <0.001). The logistic regression analysis showed the association between significant CAD and pre-diabetes was independent of other variables ( P value = 0.049, odds ratio [OR]: 2.402, 95 % CI: 1.005–5.741). In our study, severe CAD and ischemic MR were more prevalent in pre-diabetic patients than normoglycemic ones that may be indicative of pre-diabetes as a high risk state in NSTE-ACS.
No takes yet. Share an insight, caveat, or question.
Nabati et al. (2025) conducted a case-control in Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) (n=200). Pre-diabetes (HbA1c 5.7 to <6.5%) vs. Normoglycemic (HbA1c <5.7%) was evaluated on Significant coronary artery disease (OR 2.402, 95% CI 1.005-5.741, p=0.049). Pre-diabetes was independently associated with a higher likelihood of significant coronary artery disease compared to normoglycemia in non-diabetic patients with NSTE-ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: